Debruyne FM - Search Results

1

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: debruyne fm. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

2

Intravesical chemotherapy for superficial bladder cancer.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Nat Clin Pract Urol. 2004 Dec;1(2):56-7. doi: 10.1038/ncpuro0009. Nat Clin Pract Urol. 2004. PMID: 16474497 No abstract available.

3

Bladder carcinoma in patients less than 40 years of age.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Urol Int. 1989;44(2):81-3. doi: 10.1159/000281475. Urol Int. 1989. PMID: 2728130

4

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: debruyne fm. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

5

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: debruyne fm. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

6

Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.

Kiemeney LA, Witjes JA, Heijbroek RP, Debruyne FM, Verbeek AL. Kiemeney LA, et al. Among authors: debruyne fm. Eur J Cancer. 1994;30A(11):1621-5. doi: 10.1016/0959-8049(94)e0133-o. Eur J Cancer. 1994. PMID: 7833133

7

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.

Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP. Vegt PD, et al. Among authors: debruyne fm. J Urol. 1995 Mar;153(3 Pt 2):929-33. J Urol. 1995. PMID: 7853577 Clinical Trial.

8

Molecular prognostic factors in bladder cancer.

Vet JA, Debruyne FM, Schalken JA. Vet JA, et al. Among authors: debruyne fm. World J Urol. 1994;12(2):84-8. doi: 10.1007/BF00184242. World J Urol. 1994. PMID: 7916239 Review.

9

Intravesical therapy in superficial bladder cancer.

Witjes JA, Mulders PF, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Urology. 1994 Feb;43(2 Suppl):2-5; discussion 6. doi: 10.1016/0090-4295(94)90211-9. Urology. 1994. PMID: 8116130

10

Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.

Kiemeney LA, Witjes JA, Heijbroek RP, Koper NP, Verbeek AL, Debruyne FM. Kiemeney LA, et al. Among authors: debruyne fm. Br J Urol. 1994 Feb;73(2):164-71. doi: 10.1111/j.1464-410x.1994.tb07486.x. Br J Urol. 1994. PMID: 8131019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters